Myriad Genetics MYGN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Myriad Genetics's enterprise value?
- Myriad Genetics (MYGN) reported enterprise value of $506.29M in Q1 2026.
- How has Myriad Genetics's enterprise value changed year-over-year?
- Myriad Genetics's enterprise value decreased by 41.6% year-over-year, from $866.51M to $506.29M.
- What is the long-term trend for Myriad Genetics's enterprise value?
- Over 5 years (2020 to 2025), Myriad Genetics's enterprise value has grown at a -18.4% compound annual growth rate (CAGR), from $1.75B to $631.76M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.